Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma
In this GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the strategies for digital transformation shaping large and small biopharma.
Imaging Large Multiprotein Complexes Using Native Nano-DESI Mass Spectrometry
In this GEN webinar, Dr. Helen Cooper, a leading analytic alchemist from the University of Birmingham, U.K., will discuss improvements in mass spectrometry imaging technology that enable the characterization of the precise protein forms present in multiprotein complexes.
Navigating Quality Control and Release Testing in Cell and Gene Therapy Development
In this GEN webinar, our speakers will present important considerations for quality control testing for biosafety and product characterization in GMP release and stability studies of novel cell and gene therapies.
Mastering the Path: Developing Processes for Successful Clinical-Grade mRNA Manufacturing
In TOMORROW's GEN webinar, we will aim to unlock the secrets behind the iterative process development that ensures the highest standards of mRNA manufacturing.
Using Patient-Derived Organoids to Develop Novel Therapies for Complex and Inherited Diseases
In this GEN webinar, experts from Xilis and University of Washington and Plurexa will share results from recent research using patient-derived organoids to study multiple myeloma and polycystic kidney disease.
Using Oxford Nanopore’s Multi-Omic Sequencing to Optimize Plasmids and Vectors for Cell and Gene Therapies
In this GEN webinar, Andrea O'Hara, PhD, a multiomics expert at GENEWIZ from Azenta Life Sciences, will discuss how to use nanopore sequencing technology to enhance the precision and efficiency of cell and gene therapy programs.
Improving Gene Therapy Design and Manufacturability Using Synthetic Biology and AI
In this GEN webinar, Mark Stockdale will discuss how the application of synthetic biology and artificial intelligence can be used to improve the safety, potency and manufacturability of gene therapies, and introduce AAV Edge, a comprehensive platform for end-to-end gene therapy optimization—from payload design to production cell lines and model-guided processes.
Improved Methods for Characterization of AAV-Based Gene Therapies
On this GEN webinar, experts from Regeneron Pharmaceuticals, Song Nie, PhD, and Tim Tiambeng, PhD, will discuss two novel methods for characterizing AAV-based gene therapy products.
Developing iPSC-Derived Liver Systems for MASLD Modeling and Therapy Screening
In this GEN webinar, Jeremy Tomlinson, PhD, will discuss the pathogenesis of MASLD, share examples from recent research that highlight current progress and advancements in the clinic, and explore the importance of developing efficient pre-clinical models to identify and characterize novel cellular targets associated with disease progression.
Enhancing Protein Development with Active Learning-Assisted Directed Evolution
In this GEN webinar, Ravi Goel Lal from the Arnold lab at Caltech will present the basics and applications of Active Learning-assisted Directed Evolution (ALDE). He will be joined by Dr. Galit Meshulam-Simon, Associate Director of Commercial Applications at Elegen.
Endpoints: Critical Preclinical Markers in Extracellular Protein Degradation Assays
In this GEN webinar, Shyra Gardai, PhD, will demonstrate the potential of the novel extracellular degrading platform, EpiTACs, using the development of bispecific antibodies to degrade the canonical receptor tyrosine kinase epidermal growth factor receptor as a case study
Biologics Manufacturing: Maximizing Productivity Using Process Intensification
In this GEN webinar, our expert speakers will share their journey of implementing intensified technologies and its potential to improve the efficiency and cost-effectiveness of biologics manufacturing.
Alzheimer’s Disease: Early Detection and Multi-Etiology Insights from Blood-Based Immunoassays
In this GEN webinar, our expert speaker, Dr. Sterling Johnson, will discuss multi-plex blood biomarker assays, new discoveries in AD research from a large-scale study, and opportunities for early intervention during the presymptomatic phase of the disease.
Therapeutic Antibody Discovery: Selecting Effective Candidates for Emerging Viral Threats
In this GEN webinar, researchers from Vanderbilt University Medical Center will present methods for rapidly isolating and characterizing human monoclonal antibodies, particularly those targeting the SARS-CoV-2 spike protein.